KMTS - CIK 0001877184
The table below shows KESTRA MEDICAL TECHNOLOGIES, LTD.'s cash flow statement line items across its last 2 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Operating cash flow | -$77.61M | -$72.23M |
| Capital expenditure | $22.94M | $12.23M |
| Investing cash flow | -$23.31M | -$12.23M |
| Dividends paid | - | - |
| Stock buybacks | - | - |
| Financing cash flow | $330.26M | $77.72M |
KESTRA MEDICAL TECHNOLOGIES, LTD. reported operating cash flow of -$77.61M for fiscal year 2025. That is down 7.4% from -$72.23M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.